2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An Enhanced Strategy for Daily Disinfection in Acute Care Hospital Rooms : A Randomized Clinical Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This randomized clinical trial compares the efficacy of a quaternary ammonium, salt-based, 24-hour continuously active germicidal wipe vs routine disinfection in inpatient rooms.

          Key Points

          Question

          How does a quaternary ammonium, salt-based, 24-hour continuously active germicidal wipe compare with standard disinfection in acute care hospital rooms?

          Findings

          In this randomized clinical trial of inpatient rooms occupied by 50 unique patients, the median total bioburden for the intervention group was statistically significantly lower than that for the control group on study day 1. Enhanced daily disinfection decreased the environmental bioburden in acute care hospital rooms compared with routine disinfection.

          Meaning

          Findings of this study support performing large-scale randomized clinical trials to ascertain whether enhanced daily disinfection strategies can decrease patient acquisition of infection and adverse patient outcomes.

          Abstract

          Importance

          Environmental contamination is a source of transmission between patients, health care practitioners, and other stakeholders in the acute care setting.

          Objective

          To compare the efficacy of an enhanced daily disinfection strategy vs standard disinfection in acute care hospital rooms.

          Design, Setting, and Participants

          This randomized clinical trial (RCT) was conducted in acute care hospital rooms at Duke University Hospital in Durham, North Carolina, from November 2021 to March 2022. Rooms were occupied by patients with contact precautions. Room surfaces (bed rails, overbed table, and in-room sink) were divided into 2 sides (right vs left), allowing each room to serve as its own control. Each side was randomized 1:1 to the intervention group or control group.

          Interventions

          The intervention was a quaternary ammonium, salt-based, 24-hour continuously active germicidal wipe. It was applied in addition to routine disinfection for the intervention group. The control group received no intervention beyond routine disinfection.

          Main Outcomes and Measures

          The primary outcome was the total contamination, measured in colony-forming units (CFUs) on the bed rails, overbed table, and sink on study day 1. The secondary outcomes were the proportion of sample areas with positive test results for clinically important pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and carbapenem-resistant Enterobacteriaceae; the similarity in baseline contamination between sample area sides on study day 0 before application of the intervention, and the proportion of sample areas with removed UV luminescent gel on study day 1 .

          Results

          A total of 50 study rooms occupied by 50 unique patients (median [IQR] age, 61 [45-69] years; 26 men [52%]) with contact precautions were enrolled. Of these patients, 41 (82%) were actively receiving antibiotics, 39 (78%) were bedridden, and 28 (56%) had active infections with study-defined clinically important pathogens. On study day 1, the median (IQR) total CFUs for the intervention group was lower than that for the control group (3561 [1292-7602] CFUs vs 5219 [1540-12 364] CFUs; P = .002). On study day 1, the intervention side was less frequently contaminated with patient-associated clinically important pathogens compared with the control side of the room (4 [14%] vs 11 [39%]; P = .04).

          Conclusions and Relevance

          Results of this RCT demonstrated that a quaternary ammonium, salt-based, 24-hour continuously active germicidal wipe decreased the environmental bioburden in acute care hospital rooms compared with routine disinfection. The findings warrant large-scale RCTs to determine whether enhanced daily disinfection strategies can decrease patient acquisition and adverse patient outcomes.

          Trial Registration

          ClinicalTrials.gov Identifier: NCT05560321

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Multistate point-prevalence survey of health care-associated infections.

          Currently, no single U.S. surveillance system can provide estimates of the burden of all types of health care-associated infections across acute care patient populations. We conducted a prevalence survey in 10 geographically diverse states to determine the prevalence of health care-associated infections in acute care hospitals and generate updated estimates of the national burden of such infections. We defined health care-associated infections with the use of National Healthcare Safety Network criteria. One-day surveys of randomly selected inpatients were performed in participating hospitals. Hospital personnel collected demographic and limited clinical data. Trained data collectors reviewed medical records retrospectively to identify health care-associated infections active at the time of the survey. Survey data and 2010 Nationwide Inpatient Sample data, stratified according to patient age and length of hospital stay, were used to estimate the total numbers of health care-associated infections and of inpatients with such infections in U.S. acute care hospitals in 2011. Surveys were conducted in 183 hospitals. Of 11,282 patients, 452 had 1 or more health care-associated infections (4.0%; 95% confidence interval, 3.7 to 4.4). Of 504 such infections, the most common types were pneumonia (21.8%), surgical-site infections (21.8%), and gastrointestinal infections (17.1%). Clostridium difficile was the most commonly reported pathogen (causing 12.1% of health care-associated infections). Device-associated infections (i.e., central-catheter-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which have traditionally been the focus of programs to prevent health care-associated infections, accounted for 25.6% of such infections. We estimated that there were 648,000 patients with 721,800 health care-associated infections in U.S. acute care hospitals in 2011. Results of this multistate prevalence survey of health care-associated infections indicate that public health surveillance and prevention activities should continue to address C. difficile infections. As device- and procedure-associated infections decrease, consideration should be given to expanding surveillance and prevention activities to include other health care-associated infections.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

            Estimates from claims-based analyses suggest that the incidence of sepsis is increasing and mortality rates from sepsis are decreasing. However, estimates from claims data may lack clinical fidelity and can be affected by changing diagnosis and coding practices over time.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The role of the surface environment in healthcare-associated infections.

              This article reviews the evidence demonstrating the importance of contamination of hospital surfaces in the transmission of healthcare-associated pathogens and interventions scientifically demonstrated to reduce the levels of microbial contamination and decrease healthcare-associated infections.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                15 November 2022
                November 2022
                15 November 2022
                : 5
                : 11
                : e2242131
                Affiliations
                [1 ]Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina
                [2 ]Disinfection, Resistance and Transmission Epidemiology (DiRTE) Lab, Duke University School of Medicine, Durham, North Carolina
                [3 ]Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina
                Author notes
                Article Information
                Accepted for Publication: September 29, 2022.
                Published: November 15, 2022. doi:10.1001/jamanetworkopen.2022.42131
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Warren BG et al. JAMA Network Open.
                Corresponding Author: Bobby G. Warren, MPS, 325 Trent Dr, Durham, NC 27710 ( bobby.warren@ 123456duke.edu ).
                Author Contributions: Mr Warren had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Warren, Barrett, Turner, Anderson.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Warren, Graves, Anderson.
                Critical revision of the manuscript for important intellectual content: Warren, Barrett, King, Turner, Anderson.
                Statistical analysis: Warren, Barrett, Turner.
                Obtained funding: Warren, Anderson.
                Administrative, technical, or material support: Warren, Barrett, King.
                Supervision: Warren, Turner, Anderson.
                Other - Laboratory processing: Graves.
                Conflict of Interest Disclosures: Dr Turner reported receiving grants from PurioLabs Industry outside the submitted work. Dr Anderson reported receiving grants from the Centers for Disease Control and Prevention Prevention Epicenters Program, receiving personal fees from UpToDate, and being the owner of Infection Control Education for Major Sports LLC outside the submitted work. No other disclosures were reported.
                Funding/Support: Dr Turner and Mr Warren were supported by PDI Healthcare Inc.
                Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Meeting Presentation: The results of this study were presented in part at the Society for Healthcare Epidemiology of America Conference; April 13, 2022; Colorado Springs, Colorado.
                Data Sharing Statement: See Supplement 2.
                Article
                zoi221187
                10.1001/jamanetworkopen.2022.42131
                9667331
                36378308
                0eb82758-64e5-4c5c-9302-cca1d67f28cd
                Copyright 2022 Warren BG et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 13 June 2022
                : 29 September 2022
                Categories
                Research
                Original Investigation
                Online Only
                Infectious Diseases

                Comments

                Comment on this article